The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 23, 2025
Filed:
Oct. 02, 2024
Eli Lilly and Company, Indianapolis, IN (US);
Université D'aix-marseille, Marseilles, FR;
Inserm (Institut National DE LA Sante ET DE LA Recherche Medicale), Paris, FR;
Institut Jean Paoli & Irene Calmettes, Marseilles, FR;
Centre National DE LA Recherche Scientifique—cnrs, Paris, FR;
Mablink Bioscience, Lyons, FR;
Universite Claude Bernard Lyon, Villeurbanne, FR;
Jacobus Petrus Maria Elands, Forest, BE;
Joanna Fares, Aix-en-Provence, FR;
Guy Fournet, Lyons, FR;
Benoit Joseph, Villeurbanne, FR;
Florence Lhospice, Bretagne, FR;
Marc Lopez, Marseilles, FR;
Daniel Olive, Marseilles, FR;
Xavier Preville, Roquefort les Pins, FR;
Warren Viricel, Sainte Consorce, FR;
ELI LILLY AND COMPANY, Indianapolis, IN (US);
UNIVERSITÉ D'AIX-MARSEILLE, Marseilles, FR;
INSERM (Institut National De La Sante Et De La Recherche Medicale), Paris, FR;
INSTITUT JEAN PAOLI & IRENE CALMETTES, Marseilles, FR;
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE—CNRS, Paris, FR;
MABLINK BIOSCIENCE, Lyons, FR;
UNIVERSITE CLAUDE BERNARD LYON, Villeurbanne, FR;
Abstract
The present disclosure provides Nectin-4 antibody drug conjugates (ADCs) comprising exatecan and pharmaceutical compositions thereof, and methods of using the ADCs for the treatment of cancer.